Home › Alopecia Areata › Maryland
Alopecia Areata clinical trials in Maryland
5 studies for Alopecia Areata are looking for participants at sites in Maryland.
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2Healthy volunteers welcome
Ages 12 to 75 · All sexes · Updated Nov 6, 2026 · NCT05398809A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Cutaneous Translational Research Program, Johns Hopkins University School of Medicine, Baltimore
- Johns Hopkins Hospital Investigational Drug Services (IDS) Pharmacy, Baltimore
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 26, 2026 · NCT07733765A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Johns Hopkins University, Baltimore
- Dermatology and Skin Cancer Specialists, LLC, Rockville
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 20, 2026 · NCT06873945A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Kindred Hair and Skin Center, Marriottsville
RecruitingPhase 3
Ages 6 to 14 · All sexes · Updated Oct 15, 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- U.S. Dermatology Partners - Rockville, Rockville
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Jan 28, 2026 · NCT07133308From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.